Healio seeks nominees for Disruptive Innovators Awards in oncology/hematology
Healio will present its second annual Disruptive Innovators Awards for oncology/hematology this spring.
Individuals who have changed the face of the specialty and pushed the status quo to toward betterment of the field will be recognized during a prestigious awards ceremony at ASCO Annual Meeting, scheduled for June 2-6 in Chicago.
Shikha Jain, MD, FACP, and Edward S. Kim, MD, MBA, will host the event.
Healio seeks nominees in nine categories:
• Lifetime Disruptor, presented to a physician who consistently pushed the field forward through innovative treatments, practice management, patient care or research;
• Next Gen Disruptor, which recognizes an up-and-coming physician who already is disrupting the status quo in the field through new techniques, new thoughts, questioning methods or breakthrough research;
• Clinical Innovation, presented to a physician or institution that changed the face of oncology/hematology practice, providing an example of how patient care can be bettered through changes in administration, technique or delivery of value-based care;
• Woman Disruptor of the Year, presented to a woman in the field who has emerged as a leader and as an example to younger women of how a successful career can unfold;
• Healio Social Media Influencer, which recognizes a health care professional who has made a positive impact on social media, become a trusted resource for his or her peers, and led the tidal change in health care provider use within oncology/hematology;
• The Patient Voice, presented to a patient advocate or advocacy group that moved the needle with regard to discussion in the public sphere, better communication between patients and providers, and/or advocacy for legislative or regulatory action;
• Health Equity Award, which recognizes a physician who has made meaningful change to overcome the social determinants of health in oncology/hematology;
• Advanced Practitioner of the Year, presented to a nurse practitioner, nurse navigator, physician assistant, clinical nurse specialist or other advanced practitioner whose innovative approaches have improved patient outcomes or quality of care; and
• Industry Breakthrough, presented to a product that stands out as a major disruption to the practice of oncology/hematology.
Would you like to nominate a mover, shaker or industry name-maker who has spurred innovation or disrupted the practice of medicine to improve patient health or improve quality of care?
Email your nominations to Editorial Director Mark Leiser at mleiser@healio.com.
Please include the nominee’s name and institution, along with the award category for which you believe the nominee is most deserving.